Skip to main content
Premium Trial:

Request an Annual Quote

BD Biosciences, QIAGEN

Premium

BD Biosciences announced last week the launch of its DsRed-Monomer fluorescent protein. Derived from the Discosoma reef coral, DsRed-Monomer is ideal for multicolor applications in flow cytometry and fluorescence microscopy, the company said. The protein is very stable, which allows for monitoring of fluorescence over extended periods of time, the company added.

According to BD Biosciences, DsRed-Monomer is well tolerated by mammalian cells, and has been successfully used to create stably transfected, clonal cell lines.


QIAGEN announced this week the release of its Qproteome kits. Based on spin or gravity-flow columns, the kits enable fast, standardized fractionation of complex protein matrices for initial purification or preprocessing for PAGE or mass spectrometry analysis, the company said.

Kits separate proteins on the basis of glycosylation patterns, their subcellular localization, their affinity to nucleic acids, and their overall solubility. An additional kit is available for depletion of albumin and IgG from serum or plasma samples.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.